Skip to main content

Study to Explore Early Development (SEED) Follow up Studies

Agency: Centers for Disease Control and Prevention - ERA

Assistance Listings: 93.073 -- Birth Defects and Developmental Disabilities - Prevention and Surveillance

Last Updated: May 13, 2026
The purpose of this NOFO is to gain knowledge about autism spectrum disorder (ASD), including risk factors for ASD and the expression of ASD, from childhood through early adulthood, and to obtain information that can be used to improve the health and functioning of individuals with ASD as they mature. This will be completed through 1) analysis of existing data and biospecimens from preschool-aged children and their families who participated in the CDC funded study known as the Study to Explore Early Development (SEED), a multi-phase, multi-site, case-control study of children identified at age...

Eligibility

Eligible applicants

Government

  • Public and Indian housing authorities
  • City or township governments
  • Federally recognized Native American tribal governments
  • State governments
  • County governments
  • Special district governments

Business

  • For-profit organizations other than small businesses
  • Small businesses

Miscellaneous

  • Unrestricted
  • Other

Nonprofit

  • Nonprofits non-higher education without 501(c)(3)
  • Other Native American tribal organizations
  • Nonprofits non-higher education with 501(c)(3)

Education

  • Private institutions of higher education
  • Public and state institutions of higher education
  • Independent school districts

Additional information

For an application to be considered for Component A, the application must be responsive to these Special Eligibility Requirements. If your application is incomplete or non-responsive to the special eligibility requirements listed in this section, it will not enter into the review process.Component A: Access to SEED 1-3 ParticipantsAll applicants must document that they will have access to SEED participant’s individual contact and eligibility data (i.e., status on completion of the maternal interview and clinic visit, and consent for follow-up) for all cohorts they propose to include in their recruitment pool (1, 2, and/or 3) to ensure successful completion of the SEED follow-up studies outlined in Component A of the NOFO.Data for SEED 1-3 were collected under a Certificate of Confidentiality in accordance with section 301(d) of the Public Health Service Act. SEED 1-3 participants were provided assurances that only those entities that originally collected their personal information would use this information to contact them for future studies.Therefore, applicants must either:1) be the original entities that collected the original SEED data on children 2-5 years of age and their parents, and therefore have the information needed to reach these individuals for the follow-up studies;OR2) have established collaborative agreements to work with the entities that originally collected contact information from SEED participants (i.e., former SEED awardees) so that they can reach the SEED participants for the follow-up studies as outlined in this NOFO.The following entities have been funded by CDC to collect data for SEED: 1) JFK Partners and University of Colorado School of Medicine, Anschutz Medical Campus (SEED 1-3); 2) Johns Hopkins University and Kennedy Krieger Institute (SEED 1-3); 3) Washington University (SEED 3); 4) University of North Carolina at Chapel Hill (SEED 1-3); 5) The Board of Regents at the University of Wisconsin System (SEED 3); 6) Kaiser Permanente Division of Research and the California Department of Health Services (SEED 1-2); and 7) University of Pennsylvania School of Nursing and The Children’s Hospital of Pennsylvania (SEED 1-2).To be funded for Component B, C, D, or E, applicants must apply and be funded for Component A.

Grantor contact information

Description

Natalie Darling NDH6@cdc.gov

Email

Grants Policy

NDH6@cdc.gov

Documents

File nameDescriptionLast updated
DD-21-001_Amendment_1.pdf
DD-21-001 Amendment 1
Oct 23, 2020 08:07 PM UTC
RFA-DD-21-001.pdf
Revised Full Anouncement
Oct 23, 2020 08:07 PM UTC

Link to additional information

.

Archived: December 10, 2020

Application process

This site is a work in progress. Go to www.grants.gov to apply, track application status, and subscribe to updates.

Award

$16,370,000

Program Funding

11

Expected awards

$230,000

Award Minimum

$1,560,000

Award Maximum

Funding opportunity number:

RFA-DD-21-001

Cost sharing or matching requirement:

No

Funding instrument type:

Cooperative agreement

Opportunity Category:

Discretionary

Opportunity Category Explanation:

--

Category of Funding Activity:

Health

Category Explanation:

--

History

Version:

3

Posted date:

September 3, 2020

Archive date:

December 10, 2020

HHS.gov

An official website of the U.S. Department of Health and Human Services

Looking for U.S. government information and services? Visit USA.gov